69 Followers on Owler

VAXON Biotech

Read more
Kostas Kosmatopoulos's photo - CEO of VAXON Biotech

CEO

Kostas Kosmatopoulos

CEO Approval Rating

89/100

Founded:

2004

Status:

PrivateIndependent Company

Est. Annual Revenue
$4.5M
Agree?
Est. Employees
25
Agree?

VAXON Biotech News

VAXON Biotech Press Releases

Social Media

VAXON Biotech Headquarters

3 rue de l’Arrivée CIT BP 191

Paris, Île-de-France75749

07-66-03-05-55

Driving Directions »

VAXON Biotech Summary

ABOUT

Overview

VAXON Biotech researches and develops therapeutic vaccines for the treatment of lung, gastric, prostate, breast, liver and colorectal cancers. VAXON Biotech was founded in 2004. VAXON Biotech's headquarters is located in Paris, Île-de-France, FR 75749...

CEO

VAXON Biotech's CEO, Kostas Kosmatopoulos, currently has an approval rating of 89%. VAXON Biotech's primary competitors are

Competitors

There are no competitors identified for VAXON Biotech

Acquisitions

There have been no acquisitions found related to VAXON Biotech

Investments

Recent investment data cannot be found related to VAXON Biotech

Frequently Asked Questions about VAXON Biotech

  1. When was VAXON Biotech founded?

    VAXON Biotech was founded in 2004
  2. Who is VAXON Biotech's CEO?

    VAXON Biotech's CEO is Kostas Kosmatopoulos
  3. How much revenue does VAXON Biotech generate?

    VAXON Biotech generates $4.5M in revenue
  4. How much funding does VAXON Biotech have?

    VAXON Biotech has historically raised $0 in funding
  1. Where is VAXON Biotech's headquarters?

    VAXON Biotech's headquarters is in Paris Île-de-France, FR
  2. How many employees does VAXON Biotech have?

    VAXON Biotech has 25 employees
  3. What sector does VAXON Biotech operate in?

    VAXON Biotech is in Biotechnology

Trending Companies